Original Research

Once-daily indacaterol 75 µg in moderate- to-severe COPD: results of a Phase IV study assessing time until patients’ perceived onset of effect

Siler TM, LaForce CF, Kianifard F, Williams J, Spangenthal S

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:919-925

Published Date: 1 September 2014